DPDPA for Healthcare, Pharma & Clinical Research
Healthcare processes some of the most consequential personal data in the economy — medical records, diagnostic results, prescription histories, genetic information. DPDPA applies to every digital touchpoint in the patient journey.
DPDPA does not create a separate category for health data — unlike GDPR's "special category" classification. This means healthcare providers must build compliance frameworks using the same statutory provisions as every other sector, but with significantly higher risk exposure and reputational consequence for non-compliance.
DPDPA Challenges by Healthcare Sub-Sector
Hospital Chains & Multi-Specialty Facilities
Large-volume patient data processing- ›Patient registration, EMR/EHR, and diagnostic data — consent at admission vs ongoing treatment consent
- ›Employee health data of hospital staff (dual role: employer + healthcare provider)
- ›Insurance TPA data sharing — processor responsibilities for cashless claims processing
- ›Medical device data from ICU monitors, wearables, and remote patient monitoring
- ›CCTV and biometric data in hospital premises — security vs privacy balance
- ›SDF classification risk for large hospital chains processing data of millions of patients
Diagnostic Chains & Pathology Labs
High-volume test data- ›Sample collection data, test results, and referral pathways — multiple data fiduciaries in single patient journey
- ›Home collection services — location data and contact data processing
- ›B2B lab processing (tests from referring hospitals) — processor vs independent fiduciary classification
- ›Digital report delivery and retention — how long to keep test results under DPDPA
- ›Genomic and genetic testing data — heightened sensitivity despite no special category status
Pharmaceutical Companies
Research, manufacturing & pharmacovigilance- ›Clinical trial data — consent architecture for multi-site, multi-phase trials under DPDPA + CDSCO regulations
- ›Pharmacovigilance and adverse event reporting — statutory obligation vs consent requirements
- ›Medical representative data collection from doctors (prescription patterns, meeting notes)
- ›Patient support programmes and co-pay assistance — purpose limitation for commercial use of health data
- ›Cross-border clinical data transfers to global R&D centres — Section 16 intersection with ICH-GCP requirements
Telemedicine & Digital Health Platforms
Technology-mediated healthcare delivery- ›Video consultation recordings — consent for recording, retention, and access rights
- ›Prescription data and e-pharmacy integration — multi-party data sharing
- ›Health monitoring app data (BP, glucose, heart rate) — continuous consent for continuous data collection
- ›AI diagnostic tools — algorithmic processing and SDF assessment for automated health decisions
- ›Telemedicine Practice Guidelines compliance alongside DPDPA requirements
Health Insurance & TPAs
Claims processing & underwriting- ›Underwriting data processing — pre-existing conditions, lifestyle data, genetic predisposition information
- ›Claims processing data flows — hospital ↔ TPA ↔ insurer chain of data fiduciary/processor relationships
- ›Fraud investigation and data analytics — lawful basis for retrospective data analysis
- ›IRDAI data governance overlay with DPDPA requirements
- ›Group insurance data from employers — dual consent responsibilities
Biomedical Research & CROs
Clinical research organisations- ›Informed consent under DPDPA layered on ICMR ethical guidelines and CDSCO requirements
- ›Biobank data — long-term storage of biological samples and associated personal data
- ›De-identification and anonymisation standards for research — DPDPA's narrow definition of personal data
- ›Multi-country trial data flows — Section 16 compliance for global research networks
- ›Publication of research results — balancing scientific integrity with data principal rights
5 DPDPA Compliance Pillars for Healthcare
Medical Emergency Deemed Consent
Section 7 provides deemed consent for processing personal data to respond to medical emergencies. Map every emergency admission workflow to identify where Section 7 applies and where explicit Section 6 consent resumes post-stabilisation.
Section 7(a)Consent Architecture for Patient Journeys
Healthcare consent is not a single event — it spans registration, diagnosis, treatment, insurance claims, and follow-up. Build layered consent that captures purpose-specific authorisation at each stage of the patient journey.
Section 6, Rule 3-4Clinical Data Retention Mapping
Medical records have sector-specific retention requirements (Indian Medical Council regulations, state clinical establishment rules) that may conflict with DPDPA's purpose limitation. Document lawful retention bases for each data category.
Section 8(7), IMC ActProcessor Chain in Multi-Provider Care
A single patient episode involves hospitals, labs, pharmacies, insurers, and TPAs. Map fiduciary vs processor relationships in every data sharing arrangement. Section 8(2) creates effectively non-delegable responsibility.
Section 8(2), Rule 6Children's Data in Paediatric Care
Paediatric healthcare must navigate Section 9 — verifiable parental consent for children's data, subject to Rule 10-12 exemptions for prescribed categories. Age verification at registration becomes a compliance checkpoint.
Section 9, Rules 10-12ABDM and DPDPA — Convergence Requirements
ABHA (Ayushman Bharat Health Account)
Every ABHA creation involves collecting personal data (name, date of birth, mobile/Aadhaar). DPDPA consent must be obtained at ABHA creation, separate from any treatment consent. The health facility creating ABHA is the Data Fiduciary for this processing.
Health Information Exchange
When a patient shares health records from Hospital A with Hospital B through ABDM, both hospitals are independent Data Fiduciaries. Section 8(2) processor obligations do not apply — each facility has independent compliance responsibility for the data it receives.
Consent Manager Integration
ABDM uses consent artefacts for data sharing. Under DPDPA, these consent artefacts must meet Section 6 requirements — clear, specific, informed, and purpose-limited. Healthcare providers must verify that ABDM consent mechanisms satisfy DPDPA standards.
Audit Trail Requirements
Every health record access through ABDM creates a data processing event. Under Section 8, Data Fiduciaries must maintain reasonable security safeguards including access logs. ABDM audit trails and DPDPA processing records must be integrated into a single compliance framework.
Related DPDPA Resources
Healthcare Data Privacy
Full healthcare privacy deep-dive
Children's Data Protection
Section 9 for paediatric care
Compliance Checklist
8-phase implementation guide
Data Breach Response
Section 8(6) + Rule 7 protocol
Significant Data Fiduciary
Section 10 SDF obligations
Consent Management
Section 6 consent architecture
Vendor Governance
Processor chain controls
DPDPA Consulting
Counsel-led advisory services
Healthcare-Specific DPDPA Advisory
Patient data carries consequences beyond regulatory penalties. AMLEGALS brings 27 years of healthcare regulatory experience to DPDPA implementation — from hospital chains and diagnostic networks to pharma compliance and clinical trial governance.
Request a Confidential Briefing
Our data privacy counsel will reach out within one working day.
What practitioners and boards are asking
How does DPDPA apply to hospitals and healthcare providers in India?
DPDPA applies to all hospitals, clinics, diagnostic centres, and healthcare providers processing digital personal data of patients in India. This includes patient registration, medical records, diagnostic reports, billing, and insurance claims. Section 7 provides deemed consent for medical emergencies, but routine healthcare processing requires explicit consent under Section 6. Large hospital chains processing data of millions of patients may be classified as Significant Data Fiduciaries under Section 10, triggering DPO appointment, DPIA, and periodic audit obligations. AMLEGALS advises healthcare entities on DPDPA compliance including ABDM integration, clinical trial data governance, and multi provider consent architecture.